Published 20 December 2004. doi:10.1083/jcb.200410057
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 167, Number 6, 1161-1170
Persistence of apoptotic cells without autoimmune disease or inflammation in CD14/ mice
Andrew Devitt1,
Kate G. Parker3,
Carol Anne Ogden1,
Ceri Oldreive1,
Michael F. Clay1,
Lynsey A. Melville1,
Christopher O. Bellamy2,
Adam Lacy-Hulbert1,
Sophie C. Gangloff4,
Sanna M. Goyert4, and
Christopher D. Gregory1
1 Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh, EH8 9XD, Scotland, UK
2 Department of Pathology, University of Edinburgh, Edinburgh, EH8 9XD, Scotland, UK
3 School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, England, UK
4 North Shore University Hospital, Manhasset, NY 11030
Correspondence to C. Gregory: chris.gregory{at}ed.ac.uk
Interaction of macrophages with apoptotic cells involves multiple steps including recognition, tethering, phagocytosis, and anti-inflammatory macrophage responses. Defective apoptotic cell clearance is associated with pathogenesis of autoimmune disease. CD14 is a surface receptor that functions in vitro in the removal of apoptotic cells by human and murine macrophages, but its mechanism of action has not been defined. Here, we demonstrate that CD14 functions as a macrophage tethering receptor for apoptotic cells. Significantly, CD14/ macrophages in vivo are defective in clearing apoptotic cells in multiple tissues, suggesting a broad role for CD14 in the clearance process. However, the resultant persistence of apoptotic cells does not lead to inflammation or increased autoantibody production, most likely because, as we show, CD14/ macrophages retain the ability to generate anti-inflammatory signals in response to apoptotic cells. We conclude that CD14 plays a broad tethering role in apoptotic cell clearance in vivo and that apoptotic cells can persist in the absence of proinflammatory consequences.
S.C. Gangloff's present address is University of Reims Champagne Ardenne, EA2070 -IFR53, 51 100 Reims, France.
Abbreviations used in this paper: ACAMP, apoptotic cellassociated molecular pattern; ANA, anti-nuclear antibodies; AxV, annexin V; BL, Burkitt lymphoma; BMDM, bone marrowderived macrophage; HMDM, human monocyte-derived macrophage; ISEL, in situ end labelling; PAMP, pathogen-associated molecular pattern; PI, propidium iodide; PRR, pattern recognition receptor; PS, phosphatidylserine.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Komura, H., Miksa, M., Wu, R., Goyert, S. M., Wang, P.
(2009). Milk Fat Globule Epidermal Growth Factor-Factor VIII Is Down-Regulated in Sepsis via the Lipopolysaccharide-CD14 Pathway. J. Immunol.
182: 581-587
[Abstract]
[Full Text]
-
Truman, L. A., Ford, C. A., Pasikowska, M., Pound, J. D., Wilkinson, S. J., Dumitriu, I. E., Melville, L., Melrose, L. A., Ogden, C. A., Nibbs, R., Graham, G., Combadiere, C., Gregory, C. D.
(2008). CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood
112: 5026-5036
[Abstract]
[Full Text]
-
Erwig, L.-P., Henson, P. M.
(2007). Immunological Consequences of Apoptotic Cell Phagocytosis. Am. J. Pathol.
171: 2-8
[Abstract]
[Full Text]
-
Seitz, H. M., Camenisch, T. D., Lemke, G., Earp, H. S., Matsushima, G. K.
(2007). Macrophages and Dendritic Cells Use Different Axl/Mertk/Tyro3 Receptors in Clearance of Apoptotic Cells. J. Immunol.
178: 5635-5642
[Abstract]
[Full Text]
-
Knapp, S., Matt, U., Leitinger, N., van der Poll, T.
(2007). Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo. J. Immunol.
178: 993-1001
[Abstract]
[Full Text]
-
Levine, J. S., Subang, R., Nasr, S. H., Fournier, S., Lajoie, G., Wither, J., Rauch, J.
(2006). Immunization with an Apoptotic Cell-Binding Protein Recapitulates the Nephritis and Sequential Autoantibody Emergence of Systemic Lupus Erythematosus. J. Immunol.
177: 6504-6516
[Abstract]
[Full Text]
-
Lucas, M., Stuart, L. M., Zhang, A., Hodivala-Dilke, K., Febbraio, M., Silverstein, R., Savill, J., Lacy-Hulbert, A.
(2006). Requirements for Apoptotic Cell Contact in Regulation of Macrophage Responses. J. Immunol.
177: 4047-4054
[Abstract]
[Full Text]
-
Xu, W., Roos, A., Schlagwein, N., Woltman, A. M., Daha, M. R., van Kooten, C.
(2006). IL-10-producing macrophages preferentially clear early apoptotic cells. Blood
107: 4930-4937
[Abstract]
[Full Text]
-
Vandivier, R. W., Henson, P. M., Douglas, I. S.
(2006). Burying the Dead: The Impact of Failed Apoptotic Cell Removal (Efferocytosis) on Chronic Inflammatory Lung Disease. Chest
129: 1673-1682
[Abstract]
[Full Text]
-
Patel, V. A., Longacre, A., Hsiao, K., Fan, H., Meng, F., Mitchell, J. E., Rauch, J., Ucker, D. S., Levine, J. S.
(2006). Apoptotic Cells, at All Stages of the Death Process, Trigger Characteristic Signaling Events That Are Divergent from and Dominant over Those Triggered by Necrotic Cells: IMPLICATIONS FOR THE DELAYED CLEARANCE MODEL OF AUTOIMMUNITY. J. Biol. Chem.
281: 4663-4670
[Abstract]
[Full Text]
-
Sawatzky, D. A., Willoughby, D. A., Colville-Nash, P. R., Rossi, A. G.
(2006). The Involvement of the Apoptosis-Modulating Proteins ERK 1/2, Bcl-xL and Bax in the Resolution of Acute Inflammation in Vivo. Am. J. Pathol.
168: 33-41
[Abstract]
[Full Text]
-
Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., Bellamy, C. O., Lacy-Hulbert, A., Gangloff, S. C., Goyert, S. M., Gregory, C. D.
(2005). Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. JEM
201: i1-1
[Full Text]